Physician profile
Jonathan Urbanczyk
NPI 1366898744
$15,154.92
in general payments reported to CMS, 2019-2025
30 companies · $4,326 in 2025
The $4,326 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $65.24 · 2020: $379 · 2021: $364 · 2022: $1,030 · 2023: $4,516 · 2024: $4,475 · 2025: $4,326.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,858 · Travel and Lodging: $3,457 · Education: $1.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,858.37 |
| Travel and Lodging | $3,457.39 |
| Education | $1.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $4,400.13 | 2022-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Sapien 3 Ultra Resilia, Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Abbott Laboratories | $3,303.78 | 2022-2025 | Amplatzer Amulet, Coroflow, Dragonfly Opstar |
| Medtronic, INC. | $2,458.00 | 2021-2025 | Corevalve Evolut R, Symplicity G3, Onyx Frontier |
| Abiomed | $1,604.86 | 2021-2025 | Impella |
| Philips North America LLC | $1,369.06 | 2023 | (9520) Igt Devices Undivided |
| Boston Scientific Corporation | $480.29 | 2019-2025 | Avvigo Guidance System, Watchman Flx, Rotapro |
| Shockwave Medical, INC | $332.32 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Cordis US Corp. | $170.74 | 2023-2025 | Saber, Mynx Venous Vcd, Mynx Control |
| Heartflow, INC. | $144.30 | 2020 | |
| Novartis Pharmaceuticals Corporation | $88.30 | 2019-2024 | |
| Cleerly, INC. | $87.75 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Astrazeneca Pharmaceuticals LP | $87.40 | 2021 | |
| Janssen Pharmaceuticals, INC | $81.35 | 2020 | |
| Stryker Corporation | $70.39 | 2025 | Flowtriever, Clottriever Bold Catheter |
| E.R. Squibb & Sons, L.L.C. | $62.53 | 2021-2023 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $58.44 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.61 | 2020-2023 | Jardiance |
| W. L. Gore & Associates, INC. | $53.12 | 2022-2023 | Gore Cardioform Septal Occluder |
| Lantheus Medical Imaging, INC. | $52.95 | 2022-2023 | Definity |
| Portola Pharmaceuticals, LLC | $33.54 | 2020 | |
| Amgen INC. | $28.29 | 2020-2023 | Repatha |
| Siemens Medical Solutions USA, INC. | $23.81 | 2022 | |
| Pfizer INC. | $21.50 | 2023 | |
| Terumo Medical Corporation | $17.78 | 2023 | Azur Cx Detachable |
| Merck Sharp & Dohme LLC | $17.10 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $16.68 | 2022 | |
| Novo Nordisk INC | $14.64 | 2020 | |
| Teleflex LLC | $13.83 | 2023 | Guideliner |
| Cvrx, INC. | $7.43 | 2025 | Barostim Neo System |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Urbanczyk listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.